The site highlights trials, funding and regulation — useful for separating hype from deal flow, provided you read it critically.
Reports and analyses are aimed at investors; that perspective sometimes colours the framing.
News about supplements and clinics is informative, but it is not a clinical assessment.
The ‘What does the science say?’ rating is an estimate by the Engy editors based on the cited source and the wider research. Not medical advice.
As a trade outlet, it sits closer to the industry than an independent medical journal. Press releases and company announcements get relatively generous coverage.
Use it to keep track of what is happening; check health claims against peer-reviewed sources.
